MedPath

Ovarian Malignancy Incidence in Moderate Risk Women With Low CA 125

Conditions
Ovarian Cancer
Interventions
Other: Risk of malignancy index
Registration Number
NCT02247323
Lead Sponsor
Beni-Suef University
Brief Summary

The investigators are assessing the incidence of ovarian cancer in premenopausal women who were at moderate risk of malignancy with low CA125.

Detailed Description

About 10% of premenopausal women may have a surgery for ovarian masses. In premenopausal women the incidence of ovarian malignancy is 1:1000 in case of symptomatic ovarian cyst.1 CA125 is unreliable in differentiating benign from malignant ovarian mass in premenopausal women due to many false positive results and reduced specificity.1 pelvic vaginal ultrasonography is the most effective tool in evaluating ovarian masses due to increased sensitivity over abdominal US.1 An estimation of risk of malignancy index is essential in evaluating an ovarian mass.26 /2 Risk of malignancy index combines presurgical features serum including CA125, menopausal status and ultrasound findings. RMI=Ux Mx CA125 in which each feature takes a score and after calculation score less than 25 is mild, from 25-250 moderate and more than 250 has a severe risk of malignancy needing oncologist.44/3

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • Women with complex ovarian cyst
  • Abdominal pain
  • Menometrorrhagia
Exclusion Criteria
  • Significant weight loss
  • Cachexia
  • History of ovarian or other malignancy
  • Family history of ovarian Cancer

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
premenopausal womenRisk of malignancy indexpremenopausal women with complex ovarian mass moderate for malignancy by risk of malignancy index score and low CA125.
Primary Outcome Measures
NameTimeMethod
Incidence of ovarian malignancyone year

Calculation of number of women who had ovarian cancer after an operation in moderate risk

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Beni-Suef University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath